Positron Corporation (POSC)
USD 1.0
(-4.76%)
USD 1.0
(-4.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.78 Million USD | 15.71% |
| 2022 | 1.54 Million USD | 386.03% |
| 2021 | 317.84 Thousand USD | -31.31% |
| 2020 | 462.73 Thousand USD | -58.08% |
| 2019 | 1.1 Million USD | -1.36% |
| 2018 | 1.11 Million USD | 0.0% |
| 2014 | 470 Thousand USD | -90.63% |
| 2013 | 5.01 Million USD | 122.83% |
| 2012 | 2.25 Million USD | 573.95% |
| 2011 | 334 Thousand USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 1.89 Million USD | 65.04% |
| 2008 | 1.15 Million USD | 677.03% |
| 2007 | 148 Thousand USD | 322.86% |
| 2006 | 35 Thousand USD | -98.1% |
| 2005 | 1.84 Million USD | 18.9% |
| 2004 | 1.55 Million USD | 17122.22% |
| 2003 | 9000.00 USD | -99.56% |
| 2002 | 2.03 Million USD | -1.93% |
| 2001 | 2.07 Million USD | 1801.83% |
| 2000 | 109 Thousand USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 600 Thousand USD | -35.48% |
| 1997 | 930 Thousand USD | -55.14% |
| 1996 | 2.07 Million USD | 88.45% |
| 1995 | 1.1 Million USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | -100.0% |
| 1992 | 5 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.81 Million USD | 1.57% |
| 2023 FY | 1.78 Million USD | 15.71% |
| 2023 Q4 | 1.78 Million USD | -11.04% |
| 2023 Q3 | 2 Million USD | 1.42% |
| 2023 Q2 | 1.98 Million USD | 25.42% |
| 2023 Q1 | 1.57 Million USD | 2.26% |
| 2022 Q2 | 389.58 Thousand USD | 24.4% |
| 2022 Q3 | 1.46 Million USD | 275.85% |
| 2022 FY | 1.54 Million USD | 386.03% |
| 2022 Q1 | 313.16 Thousand USD | -1.47% |
| 2022 Q4 | 1.54 Million USD | 5.5% |
| 2021 FY | 317.84 Thousand USD | -31.31% |
| 2021 Q1 | 524.81 Thousand USD | 0.0% |
| 2021 Q4 | 317.84 Thousand USD | -23.19% |
| 2021 Q3 | 413.82 Thousand USD | -1.07% |
| 2021 Q2 | 418.31 Thousand USD | -20.29% |
| 2020 FY | 462.73 Thousand USD | -58.08% |
| 2019 FY | 1.1 Million USD | -1.36% |
| 2018 FY | 1.11 Million USD | 0.0% |
| 2015 Q1 | 578 Thousand USD | 22.98% |
| 2015 Q2 | 712 Thousand USD | 23.18% |
| 2015 Q3 | 962 Thousand USD | 35.11% |
| 2014 FY | 470 Thousand USD | -90.63% |
| 2014 Q4 | 470 Thousand USD | -50.73% |
| 2014 Q3 | 954 Thousand USD | -60.5% |
| 2014 Q1 | 2.15 Million USD | -57.08% |
| 2014 Q2 | 2.41 Million USD | 12.17% |
| 2013 Q1 | 3.23 Million USD | 43.89% |
| 2013 FY | 5.01 Million USD | 122.83% |
| 2013 Q4 | 5.01 Million USD | 1.64% |
| 2013 Q3 | 4.93 Million USD | 23.16% |
| 2013 Q2 | 4 Million USD | 23.71% |
| 2012 Q3 | 1.66 Million USD | 14.9% |
| 2012 Q1 | 1.3 Million USD | 291.62% |
| 2012 FY | 2.25 Million USD | 573.95% |
| 2012 Q4 | 2.25 Million USD | 35.11% |
| 2012 Q2 | 1.45 Million USD | 10.86% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | 334 Thousand USD | 0.0% |
| 2011 Q4 | 334 Thousand USD | 93.06% |
| 2011 Q3 | 173 Thousand USD | 170.31% |
| 2011 Q2 | 64 Thousand USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q1 | 1.89 Million USD | 0.0% |
| 2010 Q2 | 1.35 Million USD | -28.45% |
| 2009 Q3 | 1.77 Million USD | 0.34% |
| 2009 Q2 | 1.76 Million USD | 22.83% |
| 2009 Q1 | 1.43 Million USD | 24.96% |
| 2009 FY | 1.89 Million USD | 65.04% |
| 2009 Q4 | 1.89 Million USD | 7.17% |
| 2008 FY | 1.15 Million USD | 677.03% |
| 2008 Q3 | 406 Thousand USD | 55.56% |
| 2008 Q2 | 261 Thousand USD | 26.7% |
| 2008 Q1 | 206 Thousand USD | 39.19% |
| 2008 Q4 | 1.15 Million USD | 183.25% |
| 2007 Q2 | 62 Thousand USD | 44.19% |
| 2007 Q3 | 91 Thousand USD | 46.77% |
| 2007 Q4 | 148 Thousand USD | 62.64% |
| 2007 Q1 | 43 Thousand USD | 22.86% |
| 2007 FY | 148 Thousand USD | 322.86% |
| 2006 Q3 | 2.22 Million USD | -52.77% |
| 2006 FY | 35 Thousand USD | -98.1% |
| 2006 Q1 | 2.23 Million USD | 21.05% |
| 2006 Q2 | 4.71 Million USD | 111.43% |
| 2006 Q4 | 35 Thousand USD | -98.43% |
| 2005 Q4 | 1.84 Million USD | -9.79% |
| 2005 FY | 1.84 Million USD | 18.9% |
| 2005 Q3 | 2.04 Million USD | 40.9% |
| 2005 Q2 | 1.45 Million USD | -21.83% |
| 2005 Q1 | 1.85 Million USD | 19.68% |
| 2004 Q2 | 700 Thousand USD | 9900.0% |
| 2004 Q3 | 1.42 Million USD | 103.0% |
| 2004 Q4 | 1.55 Million USD | 9.08% |
| 2004 Q1 | 7000.00 USD | -22.22% |
| 2004 FY | 1.55 Million USD | 17122.22% |
| 2003 Q4 | 9000.00 USD | 12.5% |
| 2003 Q1 | 2.02 Million USD | -0.54% |
| 2003 FY | 9000.00 USD | -99.56% |
| 2003 Q3 | 8000.00 USD | -27.27% |
| 2003 Q2 | 11 Thousand USD | -99.46% |
| 2002 Q3 | 2.04 Million USD | -0.44% |
| 2002 Q4 | 2.03 Million USD | -0.54% |
| 2002 Q2 | 2.05 Million USD | -0.48% |
| 2002 Q1 | 2.06 Million USD | -0.48% |
| 2002 FY | 2.03 Million USD | -1.93% |
| 2001 Q4 | 2.07 Million USD | 2428.05% |
| 2001 Q3 | 82 Thousand USD | -92.48% |
| 2001 Q2 | 1.09 Million USD | 991.0% |
| 2001 Q1 | 100 Thousand USD | -8.26% |
| 2001 FY | 2.07 Million USD | 1801.83% |
| 2000 Q4 | 109 Thousand USD | -6.84% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | 117 Thousand USD | 0.0% |
| 2000 FY | 109 Thousand USD | 0.0% |
| 1999 FY | - USD | -100.0% |
| 1998 FY | 600 Thousand USD | -35.48% |
| 1997 FY | 930 Thousand USD | -55.14% |
| 1997 Q1 | 2.1 Million USD | 1.3% |
| 1996 FY | 2.07 Million USD | 88.45% |
| 1996 Q4 | 2.07 Million USD | 196.14% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1996 Q1 | - USD | -100.0% |
| 1996 Q2 | 700 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 1.1 Million USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | 1.1 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | -100.0% |
| 1992 Q4 | 5 Million USD | 0.0% |
| 1992 FY | 5 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -297.686% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -2879.222% |
| Össur hf. | 467.73 Million USD | 99.618% |
| QHSLab, Inc. | 1.78 Million USD | -0.336% |
| Wellstar International, Inc. | 51.36 Million USD | 96.52% |
| Össur hf. | 467.73 Million USD | 99.618% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | -240.665% |
| Aurora Spine Corporation | 2.67 Million USD | 33.065% |
| BrainsWay Ltd. | 471 Thousand USD | -279.519% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | 87.948% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 93.573% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -260.1% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -903.589% |
| Zecotek Photonics Inc. | 3.22 Million USD | 44.519% |
| Avitar, Inc. | 5.26 Million USD | 66.05% |
| Nanomix Corporation | 11.4 Million USD | 84.328% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 65.743% |
| Theraclion SA | 1.95 Million EUR | 8.366% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -5.239% |
| Lombard Medical, Inc. | 32.29 Million USD | 94.464% |
| ALR Technologies Inc. | 19.26 Million USD | 90.721% |
| Stratec SE | 156.16 Million USD | 98.855% |
| Vycor Medical, Inc. | 1.11 Million USD | -61.003% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -754.114% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.895% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1338675.464% |
| NewCardio, Inc. | 3 Million USD | 40.416% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 13.142% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -183.215% |
| Odyssey Group International, Inc. | 2.14 Million USD | 16.652% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -166.796% |
| Wellness Center USA, Inc. | 4.04 Million USD | 55.776% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 94.404% |
| IR-Med Inc. | 161 Thousand USD | -1010.269% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -826.692% |
| Polarean Imaging plc | 216.38 Thousand USD | -726.089% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 43.633% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -1687.533% |
| Capital Group Holdings, Inc. | 4944.00 USD | -36055.603% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -123.537% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -687.453% |
| Urologix, Inc. | 5.33 Million USD | 66.482% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 53.336% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 57.593% |
| SS Innovations International, Inc. | 8.21 Million USD | 78.249% |
| Qualis Innovations, Inc. | 9102.00 USD | -19538.904% |
| Smith & Nephew plc | 3.07 Billion USD | 99.942% |
| NIOX Group Plc | 1.4 Million USD | -27.654% |
| Fuse Medical, Inc. | 1.99 Million USD | 10.339% |
| Broncus Holding Corporation | 2.35 Million USD | 24.076% |
| Brain Scientific Inc. | 2.86 Million USD | 37.575% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 92.146% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -4319.992% |